Comparing Second-Line Therapies for Recurrent Mesothelioma
University of Pennsylvania researchers have some hopeful news for people with recurrent mesothelioma after chemotherapy: Second-line immunotherapy might increase their…
Occupational Asbestos Exposure: The Need for Standardized Assessment
A new report shows how important it is to have a standardized way to assess occupational asbestos exposure in people…
One in Three Mesothelioma Deaths Go Unreported in Brazil
Brazil has a history of underreporting mesothelioma deaths and the trend is not improving. That is the word from Brazilian…
New PD-L1 Inhibitor Could Make Mesothelioma Immunotherapy Safer
A new PD-L1 inhibitor may be on the horizon for people with malignant mesothelioma. A Phase I trial suggests it…
How Long Does Mesothelioma Risk Last After Asbestos Exposure?
If you experienced asbestos exposure more than 30 years ago and you have not developed mesothelioma, your risk for the…
Personalized Exercise Program Improves Mesothelioma Quality of Life
A new case study suggests that a personalized exercise program could improve the quality of life for people fighting malignant…
CAR-T Cells + Keytruda: New Immunotherapy for Pleural Mesothelioma?
Researchers at a top US cancer center are experimenting with a new approach to immunotherapy for pleural mesothelioma – with…
Mesothelioma Update: Drinking and Cancer Risk
A new study on the link between drinking and cancer risk may make people at risk for mesothelioma think twice…
New Studies | Prognosis | Research | Surgery | Treatments
New Test May Help Doctors Choose the Best Mesothelioma Surgery
A new predictive model may make it easier for cancer doctors to choose the best mesothelioma surgery for each pleural…
Annual Report on Cancer Death Rates: Good and Bad News for Mesothelioma Patients
The latest report on cancer death rates in the US is both good and bad news for people with malignant…